Description: HMT-3522 S1, also known as HMT-3522/wt, is a subline that has been derived from HMT-3522. The parent line was established from a benign breast tumour of a 48 year old woman and has undergone spontaneous malignant transformation. It was grown on collagen in serum-free media without antibiotics from explantation onwards. A mutation at codon 179 of the p53 gene was detected during establishment of the parent line. HMT-3522 S1 is a continuation of this line from passage 34 growing without collagen. Subline S2 (ECACC catalogue no. 98102211) has been isolated by culturing S1 cells from passage 118 in serum-free media without epidermal growth factor (EGF). The third subline, T4-2 (ECACC catalogue no. 98102212) was established from S2 at passage 238 and is the only tumorigenic line in nude mice out of the 3 sublines. S2 and T4-2 grow on collagen-coated flasks. HMT-3522 S1 is near-diploid, but an evolution of karyotype has been observed by regular chromosomal analyses. The expression of cytokeratin 13,14, 17 and 18 and vimentin has been reported. Expression of EGF-R, c-erb-B2, N-myc, c-ras-Ha1, c-ras-Ki2 and N-ras was shown to fluctuate slightly with passage number. The cells have tested negative for estrogen receptor, c-erbA1, c-erb-A2, int-2 or hst-1. During propagation growth factor requirements decreased simultaneously with amplification and overexpression of c-myc protooncogene. In a three-dimensional basement membrane culture assay the phenotypic characteristics of normal breast tissue in vivo are recapitulated. This cell line has remained non-tumorigenic for more than 400 passages. Publications using this cell line must refer to the original paper (Briand et al., In Vitro Cell Dev Biol 1987; 23:181). Any sublines created must include the name HMT-3522 in the designation, but a short name may be used in the same paper.

Also Known As:

Species: Human

Tissue: Breast

Growth Properties: Adherent

Morphology: Epithelial-like

Growth Medium: DMEM / Ham’s F12 (1:1) + 2mM Glutamine + 250ng/ml insulin + 10µg/ml transferrin +10E-8M sodium selenite + 10E-10M 17 beta-estradiol + 0.5µg/ml hydrocortisone + 5µg/ml ovine prolactin + 10ng/ml EGF

Subculturing Procedure: If starting from a frozen ampoule the cryoprotectant should be removed. Add thawed cells to a conical based centrifuge tube e.g. 15ml tube; slowly add 4 ml of culture medium to the tube. Take a sample of the cell suspension, e.g. 100µl, to count cells. Centrifuge the cell suspension at low speed i.e. 100 – 150 x g for a maximum of 5 minutes.Split subconfluent cultures using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37°C. Seed flasks at 2-4 x10, 000 cells/cm². Cells detach slowly; add same volume of trypsin inhibitor as trypsin used, centrifuge and reseed cells. Medium is serum-free, therefore trypsin inhibitor is essential. S1cells can be slow in spreading out after subculture and may take 2-3 days to attach. Good growth occurs 5-7 days after subculture. Cells should be frozen in (45% conditioned media: 45% fresh media) with 10% DMSO.

Release Conditions: No

Depositor: Dr P Briand, Department of Tumour Endocrinology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark

Originator: Yes

References: In Vitro Cell Dev Biol 1987; 23:181;Cancer Res 1992;52:1210; Cancer Res 1996;56:2039; J Cell Biol 1997; 137: 231; Genes Chromosom Cancer 1997; 20: 30; Nat Biotechnol 1997; 15: 517

Hyperlink to ECACC Cell Line Data Sheet: 98102210